GLP-1
PRODUCT · 31 article mentions
Glucagon-like peptide-1 (GLP-1) is a 30- or 31-amino-acid-long peptide hormone deriving from tissue-specific posttranslational processing of the proglucagon peptide. It is produced and secreted by intestinal enteroendocrine L-cells and certain neurons within the nucleus of the solitary tract in the brainstem upon food consumption. The initial product GLP-1 (1–37) is susceptible to amidation and proteolytic cleavage, which gives rise to the two truncated and equipotent biologically active forms, GLP-1 (7–36) amide and GLP-1 (7–37). Active GLP-1 protein secondary structure includes two α-helices from amino acid position 13–20 and 24–35 separated by a linker region.
Wikipedia: https://en.wikipedia.org/wiki/Glucagon-like_peptide-1
Wikidata: Q424611
Recent mentions
- Wegovy weight-loss pills to be available for patients in UK to buy
- Weight loss drug users save over £400 on food as take-up triples
- Whey protein shortage looms as use of weight-loss drugs fuels global demand
- GLP-1s appear to protect against cancer. Researchers are trying to figure out how
- Jim Cramer says he can't sell Eli Lilly despite its massive run up. Here's why
- Tate & Lyle agrees £2.7bn takeover by US rival in new blow to FTSE
- Weekly diabetes jab shown to reduce blood-sugar levels and body weight
- What do you mean my new smart scale is ‘built for GLP-1 users’?
- Novo Nordisk rolls out Wegovy pill in the UAE — its first market outside the U.S.
- Weight-loss drugs may prevent thousands of knee replacements, study suggests